磷脂爬行酶1(PLSCR1)调控甲型流感病毒感染中的干扰素-λ受体1(IFN-λR1)及干扰素-λ信号通路
Phospholipid scramblase 1 (PLSCR1) regulates interferon-lambda receptor 1 (IFN-λR1) and IFN-λ signaling in influenza A virus (IAV) infection
生物技术与制药领域的最新动态
Phospholipid scramblase 1 (PLSCR1) regulates interferon-lambda receptor 1 (IFN-λR1) and IFN-λ signaling in influenza A virus (IAV) infection
Edwards nets FDA approval for Sapien M3 transcatheter mitral valve replacement
Tela Bio sues BD over hernia mesh monopoly claims
Windtree offloads cardio pipeline, Vaccinex secures $60M funding in continued holiday shopping spree
Drugmakers with White House pricing deals may skirt new Medicare demos
Thermo Fisher Scientific launches PPD CorEvitas Alzheimer’s Disease Registry - scientistlive.com
10x Genomics (NASDAQ:TXG) Trading Down 4.1% - Should You Sell? - MarketBeat
Financings for Dec. 23, 2025
In the clinic for Dec. 23, 2025
Other news to note for Dec. 23, 2025
Regulatory actions for Dec. 23, 2025
Big pharma taps fast Asia innovation in search of next Keytruda
Novo Nordisk’s weight loss pill approved by FDA
Hepatic adaptation to chronic metabolic stress primes tumorigenesis
Mapping cellular targets of covalent cancer drugs in the entire mammalian body
Despite geopolitical pressures, China biotech deals remain at pace as collective value soars: Evaluate
Hope springs toward Parkinson's phase 3 despite divergent stem cell therapy data
The top 5 stock picks for biotech in 2026: William Blair
Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 - Yahoo Finance
Gilead's herpes deal; FDA approvals for Boehringer, Roche